{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05904691",
            "orgStudyIdInfo": {
                "id": "OCU-10-C-110-CS101"
            },
            "organization": {
                "fullName": "Ocugenix Corporation",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Tolerability of OCU-10-C-110 for Injection in Subjects With Neovascular Age-related Macular Degeneration",
            "officialTitle": "Safety and Tolerability of Single Ascending Doses and Multiple Repeat Doses of OCU-10-C-110 for Injection in Study Participants With Neovascular Age-related Macular Degeneration (nAMD)",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "safety-and-tolerability-of-ocu-c-for-injection-in-subjects-with-neovascular-age-related-macular-degeneration"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-05-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-05-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-06",
            "studyFirstSubmitQcDate": "2023-06-06",
            "studyFirstPostDateStruct": {
                "date": "2023-06-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-11-08",
            "lastUpdatePostDateStruct": {
                "date": "2023-11-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Ocugenix Corporation",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Multi-center, open-label, two-part safety assessment following administration of single ascending doses and repeat administration of the HTD of OCU-10-C-110 for Injection in the study eye of participants with nAMD",
            "detailedDescription": "In Part A, subjects will receive a single intravitreal dose in a single eye of the drug product. Dose will be escalated in 3 successive cohorts, pending safety. In Part B, subjects will receive 3 treatments in a single eye of drug product at 4 week intervals of the maximally tolerated dose, with an additional 4 weeks of observation for safety. ."
        },
        "conditionsModule": {
            "conditions": [
                "Neovascular Age-related Macular Degeneration (nAMD)"
            ],
            "keywords": [
                "neovascular age-related macular degeneration; intravitreal"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Multi-center, open-label, two-part safety assessment",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 19,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cohort A - Dose 1",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: OCU-10-C-110 for Injection"
                    ]
                },
                {
                    "label": "Cohort A - Dose 2",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: OCU-10-C-110 for Injection"
                    ]
                },
                {
                    "label": "Cohort A - Dose 3",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: OCU-10-C-110 for Injection"
                    ]
                },
                {
                    "label": "Cohort B - Dose TBD",
                    "type": "EXPERIMENTAL",
                    "interventionNames": [
                        "Drug: OCU-10-C-110 for Injection"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "OCU-10-C-110 for Injection",
                    "description": "OCU-10-C-110 for Injection in one of 3 doses",
                    "armGroupLabels": [
                        "Cohort A - Dose 1",
                        "Cohort A - Dose 2",
                        "Cohort A - Dose 3",
                        "Cohort B - Dose TBD"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Ocular safety - AE",
                    "description": "Number of Adverse events",
                    "timeFrame": "Cohort A - 8 weeks; Cohort B - 12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Systemic safety - AE",
                    "description": "Number of Adverse events",
                    "timeFrame": "Cohort A - 8 weeks; Cohort B - 12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Angiographically documented active choroidal neovascular (CNV) lesion (i.e., leakage on fluorescein angiography or subretinal, intraretinal, or sub-retinal pigment epithelium \\[sub-RPE\\] fluid on spectral domain optical coherence tomography \\[SD-OCT\\]) secondary to age-related macular degeneration (AMD), within the previous 10 weeks\n2. Subjects must have received, 7 to 14 days prior to the Baseline Visit, an intravitreal injection in the study eye of an anti-vascular endothelial growth factor (VEGF) ocular therapeutic approved for use in the United States\n\nExclusion Criteria:\n\n1. History or current evidence of a medical condition (systemic or ophthalmic disease, metabolic dysfunction, physical examination finding or clinical laboratory finding) that may, in the opinion of the investigator, preclude the safe administration of the study medication, adherence to the scheduled study visits, or safe participation in the study or affect the results of the study (e.g., unstable or progressive cardiovascular, cerebral vascular, pulmonary, Parkinson's, liver or renal disease, depression, cancer, or dementia)\n2. History or evidence of the following surgeries/procedures in the study eye:\n\n   1. Submacular surgery\n   2. Vitrectomy\n   3. Retinal detachment or retinal tear\n   4. Incisional glaucoma surgery",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "50 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sean McDonald",
                    "role": "CONTACT",
                    "phone": "(412) 600-6379",
                    "email": "sean@ocugenixtx.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Roger Goldberg, MD",
                    "affiliation": "Lexitas Pharma",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Raj K. Maturi, M.D., P.C.",
                    "status": "RECRUITING",
                    "city": "Carmel",
                    "state": "Indiana",
                    "zip": "46290",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lorraine White, COA OSC",
                            "role": "CONTACT",
                            "phone": "317-817-1418",
                            "email": "lorrainew@midwesteye.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.97837,
                        "lon": -86.11804
                    }
                },
                {
                    "facility": "Retina Research Institute of Texas",
                    "status": "RECRUITING",
                    "city": "Abilene",
                    "state": "Texas",
                    "zip": "79606",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Deisy Villarreal",
                            "role": "CONTACT",
                            "phone": "325-960-4414",
                            "email": "Deisy.villarreal@txicr.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.44874,
                        "lon": -99.73314
                    }
                },
                {
                    "facility": "Strategic Clinical Research Group LLC",
                    "status": "RECRUITING",
                    "city": "Willow Park",
                    "state": "Texas",
                    "zip": "76087",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ashley York",
                            "role": "CONTACT",
                            "phone": "682-703-4318",
                            "email": "ashley.york@txscrg.com"
                        },
                        {
                            "name": "Lorena Stubblefield",
                            "role": "CONTACT",
                            "phone": "(682) 703-4320",
                            "email": "lorena.stubblefield@txscrg.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.76263,
                        "lon": -97.65058
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "No sharing plans for this Phase 1 study at this time."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008268",
                    "term": "Macular Degeneration"
                },
                {
                    "id": "D000057135",
                    "term": "Wet Macular Degeneration"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012162",
                    "term": "Retinal Degeneration"
                },
                {
                    "id": "D000012164",
                    "term": "Retinal Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M11260",
                    "name": "Macular Degeneration",
                    "asFound": "Age-related Macular Degeneration",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28735",
                    "name": "Wet Macular Degeneration",
                    "asFound": "Neovascular Age-related Macular Degeneration",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14997",
                    "name": "Retinal Degeneration",
                    "relevance": "LOW"
                },
                {
                    "id": "M14999",
                    "name": "Retinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}